NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
7.97
+0.41 (5.42%)
At close: Nov 16, 2026, 4:00 PM EST
7.82
-0.15 (-1.88%)
After-hours: Nov 16, 2026, 7:39 PM EST

NeuroPace Statistics

Total Valuation

NeuroPace has a market cap or net worth of $274.58 million. The enterprise value is $294.89 million.

Market Cap274.58M
Enterprise Value 294.89M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

NeuroPace has 34.45 million shares outstanding. The number of shares has increased by 6.40% in one year.

Current Share Class 34.45M
Shares Outstanding 34.45M
Shares Change (YoY) +6.40%
Shares Change (QoQ) +0.71%
Owned by Insiders (%) 4.09%
Owned by Institutions (%) 70.90%
Float 25.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.57
Forward PS 2.68
PB Ratio 23.89
P/TBV Ratio 23.91
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.26, with a Debt / Equity ratio of 6.05.

Current Ratio 5.26
Quick Ratio 3.95
Debt / Equity 6.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.64

Financial Efficiency

Return on equity (ROE) is -96.97% and return on invested capital (ROIC) is -7.46%.

Return on Equity (ROE) -96.97%
Return on Assets (ROA) -6.31%
Return on Invested Capital (ROIC) -7.46%
Return on Capital Employed (ROCE) -12.95%
Weighted Average Cost of Capital (WACC) 13.30%
Revenue Per Employee $494,194
Profits Per Employee -$87,574
Employee Count216
Asset Turnover 1.06
Inventory Turnover 1.28

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -38.41% in the last 52 weeks. The beta is 1.93, so NeuroPace's price volatility has been higher than the market average.

Beta (5Y) 1.93
52-Week Price Change -38.41%
50-Day Moving Average 13.07
200-Day Moving Average 14.73
Relative Strength Index (RSI) 24.40
Average Volume (20 Days) 507,673

Short Selling Information

The latest short interest is 858,343, so 2.49% of the outstanding shares have been sold short.

Short Interest 858,343
Short Previous Month 886,230
Short % of Shares Out 2.49%
Short % of Float 3.34%
Short Ratio (days to cover) 8.05

Income Statement

In the last 12 months, NeuroPace had revenue of $106.75 million and -$18.92 million in losses. Loss per share was -$0.56.

Revenue106.75M
Gross Profit 83.09M
Operating Income -10.19M
Pretax Income -14.55M
Net Income -18.92M
EBITDA -9.91M
EBIT -10.19M
Loss Per Share -$0.56
Full Income Statement

Balance Sheet

The company has $49.23 million in cash and $69.54 million in debt, with a net cash position of -$20.31 million or -$0.59 per share.

Cash & Cash Equivalents 49.23M
Total Debt 69.54M
Net Cash -20.31M
Net Cash Per Share -$0.59
Equity (Book Value) 11.49M
Book Value Per Share 0.33
Working Capital 68.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.06 million and capital expenditures -$355,000, giving a free cash flow of -$12.42 million.

Operating Cash Flow -12.06M
Capital Expenditures -355,000
Depreciation & Amortization 286,000
Net Borrowing n/a
Free Cash Flow -12.42M
FCF Per Share -$0.36
Full Cash Flow Statement

Margins

Gross margin is 77.84%, with operating and profit margins of -9.55% and -17.72%.

Gross Margin 77.84%
Operating Margin -9.55%
Pretax Margin -13.63%
Profit Margin -17.72%
EBITDA Margin -9.28%
EBIT Margin -9.55%
FCF Margin n/a

Dividends & Yields

NeuroPace does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -6.40%
Shareholder Yield -6.40%
Earnings Yield -7.00%
FCF Yield -4.52%

Analyst Forecast

The average price target for NeuroPace is $12.22, which is 53.33% higher than the current price. The consensus rating is "Buy".

Price Target $12.22
Price Target Difference 53.33%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (3Y) 9.54%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NeuroPace has an Altman Z-Score of -3.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.16
Piotroski F-Score 3